The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 09, 2023
Filed:
Jul. 30, 2018
Applicants:
Theravance Biopharma R&d Ip, Llc, South San Francisco, CA (US);
Alfasigma S.p.a., Bologna, IT;
Inventors:
Christopher Noel Barnes, San Francisco, CA (US);
Giuseppe Claudio Viscomi, Bologna, IT;
Cecilia Renzulli, Bologna, IT;
Maria Grimaldi, Bologna, IT;
Assignees:
THERAVANCE BIOPHARMA R&D IP, LLC, South San Francisco, CA (US);
ALFASIGMA S.P.A., Bologna, IT;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4704 (2006.01); A61P 1/08 (2006.01); A61P 1/06 (2006.01); A61P 1/04 (2006.01); A61K 9/48 (2006.01); A61K 31/55 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4704 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 31/55 (2013.01); A61P 1/04 (2018.01); A61P 1/06 (2018.01); A61P 1/08 (2018.01);
Abstract
The present invention relates to methods and pharmaceutical compositions for treatment of all symptoms of gastroparesis in a human patient, the method comprising administering to the human patient between about 0.5 mg/day to about 30 mg/day, about 0.5 mg/day to about 15 mg/day, about 0.5 mg/day to about 5 mg/day, or about 5 mg/day, of velusetrag or a pharmaceutically-acceptable salt thereof.